The Annual Meeting is an extraordinary venue that fosters scientific discussions and helps build bridges across various disciplines. We encourage all meeting attendees to take advantage of the opportunities presented at the meeting to learn about the latest breakthroughs in the tumor microenvironment, attend sessions outside your own areas of expertise and network with other scientists and clinicians interested in all areas of cancer research.
The AACR Annual Meeting 2018 will be held in Chicago, Illinois, April 14-18.
Plan to attend these TME events during the Annual Meeting:
TME Town Hall Meeting and Reception
Interdisciplinary Approaches to the Tumor Microenvironment
Sunday, April 15, 2018, 6 - 8 p.m., Venue to be announced
Chairperson: Valerie M. Weaver, PhD, UCSF Medical Center, San Francisco, California
Chairperson-elect: Yibin Kang, PhD, Princeton University, Princeton, New Jersey
This event will provide an opportunity for all interested attendees to hear insights from our colleagues on the tumor microenvironment in relation to metastasis regulation. In addition to the presentations, guests will learn about other important TME initiatives, meet members of the working group and steering committee, and investigate the opportunity to join the TME Working Group. A networking reception follows the program.
Celeste M. Nelson, PhD, Princeton University, Princeton, New Jersey
Tissue mechanics, EMT, and genomic instability
Sunil R. Hingorani, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, Washington
presentation title to be announced
Amanda W. Lund, PhD, Oregon Health & Science University, Portland, Oregon
Lymphatic vessels: sensors and regulators of anti-tumor immunity
Joint Cancer Immunology / Tumor Microenvironment (TME) Working Groups Evening Scientific Session
Overcoming a Hostile Immune Microenvironment
Monday, April 16, 2018; 6 - 8 p.m., Venue to be announced
The chairpersons of the Cancer Immunology (CIMM) and the Tumor Microenvironment (TME) Working Groups invite you to attend this stimulating program to hear the perspective of leaders in the field.
Jedd D. Wolchok, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, New York(CIMM chairperson)
Valerie M. Weaver, PhD, University of California at San Francisco Medical Center,
San Francisco, California (TME chairperson)
F. Stephen Hodi, MD, Dana-Farber Cancer Institute, Boston, Massachusetts
Combinatorial Approaches to Checkpoint Blockade
Douglas T. Fearon, MD, PhD, Cold Spring Harbor Laboratory and Weill Cornell Medical College, Cold Spring Harbor, New York
Results from a phase 1 clinical trial of CXCR4 inhibition in cancers resistant to T cell checkpoint antagonists
Johanna A. Joyce, PhD, University of Lausanne, Ludwig Institute for Cancer Research, Lausanne, Switzerland
Microenvironmental regulation of cancer metastasis and therapeutic efficacy
TME Special Networking Session with Early-career researchers
Perspectives on career diversity in tumor-immunology
Monday, April 16, 2018, 11:45 a.m. -12:30 p.m.; McCormick Place Convention Center, Exhibit Hall A, AACRcentral Amphitheater, Booth #2312
This networking session will provide an opportunity for
early-career researchers to interact with the TME Working Group leadership and other
experts in the field of the tumor microenvironment, and to learn about career
challenges and opportunities in various fields of TME research. This informative discussion will provide ample time for comments and questions.